QQQ   430.55 (-0.12%)
AAPL   168.68 (-2.32%)
MSFT   415.54 (+0.46%)
META   500.71 (+0.10%)
GOOGL   154.27 (-0.38%)
AMZN   183.23 (-0.21%)
TSLA   155.87 (-3.47%)
NVDA   871.06 (+1.28%)
AMD   162.55 (+1.39%)
NIO   3.81 (-2.06%)
BABA   69.89 (-1.03%)
T   16.00 (-1.48%)
F   12.13 (-0.82%)
MU   120.71 (-0.54%)
GE   155.63 (+1.26%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.76 (+11.74%)
PFE   25.80 (-0.42%)
PYPL   63.66 (+0.24%)
XOM   118.23 (-1.21%)
QQQ   430.55 (-0.12%)
AAPL   168.68 (-2.32%)
MSFT   415.54 (+0.46%)
META   500.71 (+0.10%)
GOOGL   154.27 (-0.38%)
AMZN   183.23 (-0.21%)
TSLA   155.87 (-3.47%)
NVDA   871.06 (+1.28%)
AMD   162.55 (+1.39%)
NIO   3.81 (-2.06%)
BABA   69.89 (-1.03%)
T   16.00 (-1.48%)
F   12.13 (-0.82%)
MU   120.71 (-0.54%)
GE   155.63 (+1.26%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.76 (+11.74%)
PFE   25.80 (-0.42%)
PYPL   63.66 (+0.24%)
XOM   118.23 (-1.21%)
QQQ   430.55 (-0.12%)
AAPL   168.68 (-2.32%)
MSFT   415.54 (+0.46%)
META   500.71 (+0.10%)
GOOGL   154.27 (-0.38%)
AMZN   183.23 (-0.21%)
TSLA   155.87 (-3.47%)
NVDA   871.06 (+1.28%)
AMD   162.55 (+1.39%)
NIO   3.81 (-2.06%)
BABA   69.89 (-1.03%)
T   16.00 (-1.48%)
F   12.13 (-0.82%)
MU   120.71 (-0.54%)
GE   155.63 (+1.26%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.76 (+11.74%)
PFE   25.80 (-0.42%)
PYPL   63.66 (+0.24%)
XOM   118.23 (-1.21%)
QQQ   430.55 (-0.12%)
AAPL   168.68 (-2.32%)
MSFT   415.54 (+0.46%)
META   500.71 (+0.10%)
GOOGL   154.27 (-0.38%)
AMZN   183.23 (-0.21%)
TSLA   155.87 (-3.47%)
NVDA   871.06 (+1.28%)
AMD   162.55 (+1.39%)
NIO   3.81 (-2.06%)
BABA   69.89 (-1.03%)
T   16.00 (-1.48%)
F   12.13 (-0.82%)
MU   120.71 (-0.54%)
GE   155.63 (+1.26%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.76 (+11.74%)
PFE   25.80 (-0.42%)
PYPL   63.66 (+0.24%)
XOM   118.23 (-1.21%)
OTCMKTS:CURLF

Curaleaf (CURLF) Stock Price, News & Analysis

$4.83
0.00 (0.00%)
(As of 04/15/2024 ET)
Today's Range
$4.73
$5.05
50-Day Range
$3.85
$5.66
52-Week Range
$2.19
$5.91
Volume
447,130 shs
Average Volume
683,208 shs
Market Capitalization
$3.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.75

Curaleaf MarketRank™ Stock Analysis

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
288.2% Upside
$18.75 Price Target
Short Interest
Healthy
0.73% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.45mentions of Curaleaf in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.18) to ($0.07) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.39 out of 5 stars

CURLF stock logo

About Curaleaf Stock (OTCMKTS:CURLF)

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

CURLF Stock Price History

CURLF Stock News Headlines

3 Cannabis Penny Stocks to Buy for 3-Bagger Returns
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Wake Up to Wealth: 7 Sleeper Stocks Ready to Roar
See More Headlines
Receive CURLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/16/2024
Next Earnings (Estimated)
4/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:CURLF
Fax
N/A
Employees
5,650
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.75
High Stock Price Target
$32.25
Low Stock Price Target
$5.25
Potential Upside/Downside
+288.2%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-281,200,000.00
Pretax Margin
-9.24%

Debt

Sales & Book Value

Annual Sales
$1.35 billion
Cash Flow
$0.15 per share
Book Value
$1.64 per share

Miscellaneous

Free Float
N/A
Market Cap
$3.10 billion
Optionable
Not Optionable
Beta
1.77
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Boris Alexis Jordan (Age 58)
    Executive Chairman
    Comp: $1.75M
  • Mr. Matthew S. Darin
    Chief Executive Officer
  • Mr. Joseph F. Lusardi (Age 50)
    Executive Vice-Chairman
    Comp: $657.7k
  • Mr. Edward Kremer (Age 52)
    Chief Financial Officer
    Comp: $461.74k
  • Mr. Camilo Russi Lyon
    Chief Investment Officer
  • Mr. Jakob Feinstein
    Manager of Investor Relations
  • Mr. Peter Laurence Clateman J.D. (Age 56)
    Chief Legal Officer
  • Mr. James S. Shorris (Age 63)
    Chief Compliance Officer
  • Ms. Tracy Brady
    Senior Vice President of Corporate Communications
  • Ms. Kate Lynch
    Executive Vice President of Marketing

CURLF Stock Analysis - Frequently Asked Questions

Should I buy or sell Curaleaf stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last year. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CURLF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CURLF, but not buy additional shares or sell existing shares.
View CURLF analyst ratings
or view top-rated stocks.

What is Curaleaf's stock price target for 2024?

5 analysts have issued 12-month price targets for Curaleaf's stock. Their CURLF share price targets range from $5.25 to $32.25. On average, they expect the company's stock price to reach $18.75 in the next twelve months. This suggests a possible upside of 288.2% from the stock's current price.
View analysts price targets for CURLF
or view top-rated stocks among Wall Street analysts.

How have CURLF shares performed in 2024?

Curaleaf's stock was trading at $4.06 at the beginning of 2024. Since then, CURLF stock has increased by 19.0% and is now trading at $4.83.
View the best growth stocks for 2024 here
.

Are investors shorting Curaleaf?

Curaleaf saw a increase in short interest in February. As of February 29th, there was short interest totaling 5,055,000 shares, an increase of 5.3% from the February 14th total of 4,799,400 shares. Based on an average trading volume of 978,900 shares, the short-interest ratio is currently 5.2 days.
View Curaleaf's Short Interest
.

When is Curaleaf's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024.
View our CURLF earnings forecast
.

How were Curaleaf's earnings last quarter?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) announced its quarterly earnings results on Wednesday, March, 6th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.05) by $0.04. The company earned $345.27 million during the quarter, compared to analysts' expectations of $336.64 million. Curaleaf had a negative trailing twelve-month return on equity of 12.93% and a negative net margin of 20.77%.

How do I buy shares of Curaleaf?

Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CURLF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners